Categories: News

Neutra Poised for Greater Growth as Another Successful Year Comes to a Close

KATY, TX / ACCESSWIRE / December 18, 2020 / Neutra Corporation (OTC PINK:NTRR) has enjoyed a year of important milestones and achievements that have set up the company for a strong 2021. These accomplishments are even more impressive considering the world saw the onset of a global pandemic in March that continues to this day.

Among the biggest highlights for 2020 include:

  • a fresh influx of funding
  • the retiring of convertible debt
  • the granting of hemp processing and handling from the state of Texas
  • the opening of manufacturing facilities in the Greater Houston area
  • the rollout of several new zero-THC products, including Broad-Spectrum CBD Products
  • expansion into equipment rental and consulting
  • and finally, the hiring of a national sales team

“It’s obviously been a year of great challenges because of COVID, but thanks to careful planning and a lot of hard work, Neutra is wrapping up its most successful year to date,” said CEO Sydney Jim. “I’m proud to inform our valued shareholders that we’ve met our goals for the year and we’re aiming much higher for 2021. We’re in a great position to accomplish even greater things in the coming 12 months in no small part due to our past success.”

One of the items that will help Neutra get off to a good start next is a new pain cream to be produced by its VIVIS subsidiary. This pain cream will deliver superior relief for users through a broad spectrum CBD dosage of 1000 mg. The market potential for this pain cream is vast as more than 116 million Americans suffer from chronic pain issues.

To learn more about these and other VIVIS hemp-based CBD products, visit the company’s website at http://viviscbd.com.

About Neutra Corp.

Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.

NOTICE REGARDING FORWARD LOOKING STATEMENT

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:

Sydney Jim
888-433-4033
info@neutrainc.com

SOURCE: Neutra Corp

View source version on accesswire.com:
https://www.accesswire.com/621525/Neutra-Poised-for-Greater-Growth-as-Another-Successful-Year-Comes-to-a-Close

Staff

Recent Posts

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…

6 hours ago

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

6 hours ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…

6 hours ago

Music’s Healing Influence on Our Physiology

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…

9 hours ago

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…

9 hours ago

Mending Kids’ Imagine Gala Triumphs, Elevating Children’s Surgical Care Initiatives

LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Skirball Cultural Center was…

9 hours ago